Global Drug Delivery Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Publisher Name :
Date: 02-Sep-2022
No. of pages: 130
Inquire Before Buying

Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug delivery devices corresponding to the medicine taken ways, such as syringe, spray bottle and implantable drug delivery devices etc.

Highlights

Considering the economic change due to COVID-19 and Russia-Ukraine War Influence, the global Drug Delivery Devices market is projected to reach US$ 58080 million by 2028 from an estimated US$ 43590 million in 2022, at a CAGR of 4.9% during 2023 and 2028.

The top five global manufacturers of drug delivery equipment are Cipla, Baxter International, Nipro Corporation, Roche and Boehringer Ingelheim, with a combined market share of 29 per cent. North America, which has a well-established healthcare infrastructure and a large number of leading pharmaceutical and biopharmaceutical companies (around 80% of the world's research and development in biopharmaceutical is conducted by US-based firms), is the largest market for drug delivery, about for 47% followed by Europe with 28%.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Drug Delivery Devices, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyse their position in the current marketplace, and make informed business decisions regarding Drug Delivery Devices.

The Drug Delivery Devices market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2021 as the base year, with history and forecast data for the period from 2017 to 2028. This report segments the global Drug Delivery Devices market comprehensively. Regional market sizes, concerning products by type, by application, and by players, are also provided. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Drug Delivery Devices companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue by companies for the period 2017-2022. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses. Some of the prominent players reviewed in the research report include:

- Cipla

- Baxter International

- Nipro Corporation

- Roche

- Boehringer Ingelheim

- Allergan

- 3M

- BD

- Catalent

- Valeant Pharmaceuticals

- Bayer AG

- Chiesi

- Phillips-Medisize

- Johnson & Johnson

- Shandong Weigao

- Pfizer

- B.Braun

- Novartis AG

- Zhengkang

- Gerresheimer

- COVIDIEN Medtronic

- Schott forma vitrum

- Alkermes

- Skyepharma

Product Type Insights

Global markets are presented by Drug Delivery Devices type, along with growth forecasts through 2028. Estimates on revenue are based on the price in the supply chain at which the Drug Delivery Devices are procured by the companies.

This report has studied every segment and provided the market size using historical data. They have also talked about the growth opportunities that the segment may pose in the future. This study bestows revenue data by type, and during the historical period (2017-2022) and forecast period (2023-2028).

Drug Delivery Devices Segment by Type

- Injection Type

- Mucosal Type

- Implanted Type

- Others Type

Application Insights

This report has provided the market size (revenue data) by application, during the historical period (2017-2022) and forecast period (2023-2028).

This report also outlines the market trends of each segment and consumer behaviors impacting the Drug Delivery Devices market and what implications these may have on the industry's future. This report can help to understand the relevant market and consumer trends that are driving the Drug Delivery Devices market.

Drug Delivery Devices Segment by Application

- Pharmaceutical Companies

- Hospitals

- Clinics

- Other

Regional Outlook

This section of the report provides key insights regarding various regions and the key players operating in each region. Economic, social, environmental, technological, and political factors have been taken into consideration while assessing the growth of the particular region/country. The readers will also get their hands on the revenue of each region and country for the period 2017-2028.

The market has been segmented into various major geographies, including North America, Europe, Asia-Pacific, South America, Middle East & Africa. Detailed analysis of major countries such as the USA, Germany, the U.K., Italy, France, China, Japan, South Korea, Southeast Asia, and India will be covered within the regional segment. For market estimates, data are going to be provided for 2021 because of the base year, with estimates for 2022 and forecast revenue for 2028.

- North America

- - United States

- - Canada

- Europe

- - Germany

- - France

- - U.K.

- - Italy

- - Russia

- - Nordic Countries

- - Benelux

- - Rest of Europe

- Asia-Pacific

- - China

- - Japan

- - South Korea

- - India

- - Southeast Asia

- - Australia

- - Rest of Asia-Pacific

- Latin America

- - Mexico

- - Brazil

- - Argentina

- - Rest of Latin America

- Middle East & Africa

- - Turkey

- - Saudi Arabia

- - UAE

- - Rest of Middle East & Africa

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

COVID-19 and Russia-Ukraine War Influence Analysis

The readers in the section will understand how the Drug Delivery Devices market scenario changed across the globe during the pandemic, post-pandemic and Russia-Ukraine War. The study is done keeping in view the changes in aspects such as demand, consumption, transportation, consumer behavior, supply chain management. The industry experts have also highlighted the key factors that will help create opportunities for players and stabilize the overall industry in the years to come.

Reasons to Buy This Report

This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Drug Delivery Devices market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

This report will help stakeholders to understand the global industry status and trends of Drug Delivery Devices and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

This report stays updated with novel technology integration, features, and the latest developments in the market

This report helps stakeholders to understand the COVID-19 and Russia-Ukraine War Influence on the Drug Delivery Devices industry.

This report helps stakeholders to gain insights into which regions to target globally.

This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Drug Delivery Devices.

This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Global Drug Delivery Devices Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2022-2028

Table of Contents
1 Study Coverage
1.1 Drug Delivery Devices Product Introduction
1.2 Market by Type
1.2.1 Global Drug Delivery Devices Market Size Growth Rate by Type (2017 VS 2021 VS 2028)
1.2.2 Injection Type
1.2.3 Mucosal Type
1.2.4 Implanted Type
1.2.5 Others Type
1.3 Market by Application
1.3.1 Global Drug Delivery Devices Market Size Growth Rate by Application (2017 VS 2021 VS 2028)
1.3.2 Pharmaceutical Companies
1.3.3 Hospitals
1.3.4 Clinics
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Drug Delivery Devices Market Size Estimates and Forecasts
2.2 Drug Delivery Devices Market Size by Region: 2022 Versus 2028
2.2.1 Global Drug Delivery Devices Revenue by Region: 2017-2022
2.2.2 Global Drug Delivery Devices Revenue Forecast by Region (2023-2028)
2.2.3 Global Drug Delivery Devices Revenue Market Share by Region (2017-2028)
3 Global Drug Delivery Devices by Company
3.1 Global Drug Delivery Devices Revenue by Company (2017-2022)
3.2 Global Drug Delivery Devices Revenue Share by Company (2017-2022)
3.3 Competitive Landscape
3.3.1 Key Drug Delivery Devices Companies around the World: Ranking by Revenue
3.3.2 Global Drug Delivery Devices Market Concentration Ratio (CR5 and HHI) & (2017-2022)
3.3.3 Global Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.4 Global Drug Delivery Devices Companies Headquarters & Product Type
3.4.1 Drug Delivery Devices Companies Headquarters
3.4.2 Global Drug Delivery Devices Companies Product & Service
3.4.3 Date of International Companies Enter into Drug Delivery Devices Market
3.5 Global Drug Delivery Devices Mergers & Acquisitions, Expansion Plans
4 Company Profiles
4.1 Cipla
4.1.1 Cipla Corporation Information
4.1.2 Cipla Description, Business Overview
4.1.3 Cipla Drug Delivery Devices Products Offered
4.1.4 Cipla Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.1.5 Cipla Drug Delivery Devices Revenue by Product in 2021
4.1.6 Cipla Drug Delivery Devices Revenue by Application in 2021
4.1.7 Cipla Drug Delivery Devices Revenue by Geographic Area in 2021
4.1.8 Cipla Recent Developments
4.2 Baxter International
4.2.1 Baxter International Corporation Information
4.2.2 Baxter International Description, Business Overview
4.2.3 Baxter International Drug Delivery Devices Products Offered
4.2.4 Baxter International Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.2.5 Baxter International Drug Delivery Devices Revenue by Product in 2021
4.2.6 Baxter International Drug Delivery Devices Revenue by Application in 2021
4.2.7 Baxter International Drug Delivery Devices Revenue by Geographic Area in 2021
4.2.8 Baxter International Recent Developments
4.3 Nipro Corporation
4.3.1 Nipro Corporation Corporation Information
4.3.2 Nipro Corporation Description, Business Overview
4.3.3 Nipro Corporation Drug Delivery Devices Products Offered
4.3.4 Nipro Corporation Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.3.5 Nipro Corporation Drug Delivery Devices Revenue by Product in 2021
4.3.6 Nipro Corporation Drug Delivery Devices Revenue by Application in 2021
4.3.7 Nipro Corporation Drug Delivery Devices Revenue by Geographic Area in 2021
4.3.8 Nipro Corporation Recent Developments
4.4 Roche
4.4.1 Roche Corporation Information
4.4.2 Roche Description, Business Overview
4.4.3 Roche Drug Delivery Devices Products Offered
4.4.4 Roche Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.4.5 Roche Drug Delivery Devices Revenue by Product in 2021
4.4.6 Roche Drug Delivery Devices Revenue by Application in 2021
4.4.7 Roche Drug Delivery Devices Revenue by Geographic Area in 2021
4.4.8 Roche Recent Developments
4.5 Boehringer Ingelheim
4.5.1 Boehringer Ingelheim Corporation Information
4.5.2 Boehringer Ingelheim Description, Business Overview
4.5.3 Boehringer Ingelheim Drug Delivery Devices Products Offered
4.5.4 Boehringer Ingelheim Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.5.5 Boehringer Ingelheim Drug Delivery Devices Revenue by Product in 2021
4.5.6 Boehringer Ingelheim Drug Delivery Devices Revenue by Application in 2021
4.5.7 Boehringer Ingelheim Drug Delivery Devices Revenue by Geographic Area in 2021
4.5.8 Boehringer Ingelheim Recent Developments
4.6 Allergan
4.6.1 Allergan Corporation Information
4.6.2 Allergan Description, Business Overview
4.6.3 Allergan Drug Delivery Devices Products Offered
4.6.4 Allergan Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.6.5 Allergan Drug Delivery Devices Revenue by Product in 2021
4.6.6 Allergan Drug Delivery Devices Revenue by Application in 2021
4.6.7 Allergan Drug Delivery Devices Revenue by Geographic Area in 2021
4.6.8 Allergan Recent Development
4.7 3M
4.7.1 3M Corporation Information
4.7.2 3M Description, Business Overview
4.7.3 3M Drug Delivery Devices Products Offered
4.7.4 3M Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.7.5 3M Drug Delivery Devices Revenue by Product in 2021
4.7.6 3M Drug Delivery Devices Revenue by Application in 2021
4.7.7 3M Drug Delivery Devices Revenue by Geographic Area in 2021
4.7.8 3M Recent Development
4.8 BD
4.8.1 BD Corporation Information
4.8.2 BD Description, Business Overview
4.8.3 BD Drug Delivery Devices Products Offered
4.8.4 BD Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.8.5 BD Drug Delivery Devices Revenue by Product in 2021
4.8.6 BD Drug Delivery Devices Revenue by Application in 2021
4.8.7 BD Drug Delivery Devices Revenue by Geographic Area in 2021
4.8.8 BD Recent Development
4.9 Catalent
4.9.1 Catalent Corporation Information
4.9.2 Catalent Description, Business Overview
4.9.3 Catalent Drug Delivery Devices Products Offered
4.9.4 Catalent Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.9.5 Catalent Drug Delivery Devices Revenue by Product in 2021
4.9.6 Catalent Drug Delivery Devices Revenue by Application in 2021
4.9.7 Catalent Drug Delivery Devices Revenue by Geographic Area in 2021
4.9.8 Catalent Recent Development
4.10 Valeant Pharmaceuticals
4.10.1 Valeant Pharmaceuticals Corporation Information
4.10.2 Valeant Pharmaceuticals Description, Business Overview
4.10.3 Valeant Pharmaceuticals Drug Delivery Devices Products Offered
4.10.4 Valeant Pharmaceuticals Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.10.5 Valeant Pharmaceuticals Drug Delivery Devices Revenue by Product in 2021
4.10.6 Valeant Pharmaceuticals Drug Delivery Devices Revenue by Application in 2021
4.10.7 Valeant Pharmaceuticals Drug Delivery Devices Revenue by Geographic Area in 2021
4.10.8 Valeant Pharmaceuticals Recent Development
4.11 Bayer AG
4.11.1 Bayer AG Corporation Information
4.11.2 Bayer AG Description, Business Overview
4.11.3 Bayer AG Drug Delivery Devices Products Offered
4.11.4 Bayer AG Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.11.5 Bayer AG Drug Delivery Devices Revenue by Product in 2021
4.11.6 Bayer AG Drug Delivery Devices Revenue by Application in 2021
4.11.7 Bayer AG Drug Delivery Devices Revenue by Geographic Area in 2021
4.11.8 Bayer AG Recent Development
4.12 Chiesi
4.12.1 Chiesi Corporation Information
4.12.2 Chiesi Description, Business Overview
4.12.3 Chiesi Drug Delivery Devices Products Offered
4.12.4 Chiesi Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.12.5 Chiesi Drug Delivery Devices Revenue by Product in 2021
4.12.6 Chiesi Drug Delivery Devices Revenue by Application in 2021
4.12.7 Chiesi Drug Delivery Devices Revenue by Geographic Area in 2021
4.12.8 Chiesi Recent Development
4.13 Phillips-Medisize
4.13.1 Phillips-Medisize Corporation Information
4.13.2 Phillips-Medisize Description, Business Overview
4.13.3 Phillips-Medisize Drug Delivery Devices Products Offered
4.13.4 Phillips-Medisize Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.13.5 Phillips-Medisize Drug Delivery Devices Revenue by Product in 2021
4.13.6 Phillips-Medisize Drug Delivery Devices Revenue by Application in 2021
4.13.7 Phillips-Medisize Drug Delivery Devices Revenue by Geographic Area in 2021
4.13.8 Phillips-Medisize Recent Development
4.14 Johnson & Johnson
4.14.1 Johnson & Johnson Corporation Information
4.14.2 Johnson & Johnson Description, Business Overview
4.14.3 Johnson & Johnson Drug Delivery Devices Products Offered
4.14.4 Johnson & Johnson Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.14.5 Johnson & Johnson Drug Delivery Devices Revenue by Product in 2021
4.14.6 Johnson & Johnson Drug Delivery Devices Revenue by Application in 2021
4.14.7 Johnson & Johnson Drug Delivery Devices Revenue by Geographic Area in 2021
4.14.8 Johnson & Johnson Recent Development
4.15 Shandong Weigao
4.15.1 Shandong Weigao Corporation Information
4.15.2 Shandong Weigao Description, Business Overview
4.15.3 Shandong Weigao Drug Delivery Devices Products Offered
4.15.4 Shandong Weigao Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.15.5 Shandong Weigao Drug Delivery Devices Revenue by Product in 2021
4.15.6 Shandong Weigao Drug Delivery Devices Revenue by Application in 2021
4.15.7 Shandong Weigao Drug Delivery Devices Revenue by Geographic Area in 2021
4.15.8 Shandong Weigao Recent Development
4.16 Pfizer
4.16.1 Pfizer Corporation Information
4.16.2 Pfizer Description, Business Overview
4.16.3 Pfizer Drug Delivery Devices Products Offered
4.16.4 Pfizer Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.16.5 Pfizer Drug Delivery Devices Revenue by Product in 2021
4.16.6 Pfizer Drug Delivery Devices Revenue by Application in 2021
4.16.7 Pfizer Drug Delivery Devices Revenue by Geographic Area in 2021
4.16.8 Pfizer Recent Development
4.17 B.Braun
4.17.1 B.Braun Corporation Information
4.17.2 B.Braun Description, Business Overview
4.17.3 B.Braun Drug Delivery Devices Products Offered
4.17.4 B.Braun Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.17.5 B.Braun Drug Delivery Devices Revenue by Product in 2021
4.17.6 B.Braun Drug Delivery Devices Revenue by Application in 2021
4.17.7 B.Braun Drug Delivery Devices Revenue by Geographic Area in 2021
4.17.8 B.Braun Recent Development
4.18 Novartis AG
4.18.1 Novartis AG Corporation Information
4.18.2 Novartis AG Description, Business Overview
4.18.3 Novartis AG Drug Delivery Devices Products Offered
4.18.4 Novartis AG Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.18.5 Novartis AG Drug Delivery Devices Revenue by Product in 2021
4.18.6 Novartis AG Drug Delivery Devices Revenue by Application in 2021
4.18.7 Novartis AG Drug Delivery Devices Revenue by Geographic Area in 2021
4.18.8 Novartis AG Recent Development
4.19 Zhengkang
4.19.1 Zhengkang Corporation Information
4.19.2 Zhengkang Description, Business Overview
4.19.3 Zhengkang Drug Delivery Devices Products Offered
4.19.4 Zhengkang Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.19.5 Zhengkang Drug Delivery Devices Revenue by Product in 2021
4.19.6 Zhengkang Drug Delivery Devices Revenue by Application in 2021
4.19.7 Zhengkang Drug Delivery Devices Revenue by Geographic Area in 2021
4.19.8 Zhengkang Recent Development
4.20 Gerresheimer
4.20.1 Gerresheimer Corporation Information
4.20.2 Gerresheimer Description, Business Overview
4.20.3 Gerresheimer Drug Delivery Devices Products Offered
4.20.4 Gerresheimer Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.20.5 Gerresheimer Drug Delivery Devices Revenue by Product in 2021
4.20.6 Gerresheimer Drug Delivery Devices Revenue by Application in 2021
4.20.7 Gerresheimer Drug Delivery Devices Revenue by Geographic Area in 2021
4.20.8 Gerresheimer Recent Development
4.21 COVIDIEN Medtronic
4.21.1 COVIDIEN Medtronic Corporation Information
4.21.2 COVIDIEN Medtronic Description, Business Overview
4.21.3 COVIDIEN Medtronic Drug Delivery Devices Products Offered
4.21.4 COVIDIEN Medtronic Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.21.5 COVIDIEN Medtronic Drug Delivery Devices Revenue by Product in 2021
4.21.6 COVIDIEN Medtronic Drug Delivery Devices Revenue by Application in 2021
4.21.7 COVIDIEN Medtronic Drug Delivery Devices Revenue by Geographic Area in 2021
4.21.8 COVIDIEN Medtronic Recent Development
4.22 Schott forma vitrum
4.22.1 Schott forma vitrum Corporation Information
4.22.2 Schott forma vitrum Description, Business Overview
4.22.3 Schott forma vitrum Drug Delivery Devices Products Offered
4.22.4 Schott forma vitrum Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.22.5 Schott forma vitrum Drug Delivery Devices Revenue by Product in 2021
4.22.6 Schott forma vitrum Drug Delivery Devices Revenue by Application in 2021
4.22.7 Schott forma vitrum Drug Delivery Devices Revenue by Geographic Area in 2021
4.22.8 Schott forma vitrum Recent Development
4.23 Alkermes
4.23.1 Alkermes Corporation Information
4.23.2 Alkermes Description, Business Overview
4.23.3 Alkermes Drug Delivery Devices Products Offered
4.23.4 Alkermes Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.23.5 Alkermes Drug Delivery Devices Revenue by Product in 2021
4.23.6 Alkermes Drug Delivery Devices Revenue by Application in 2021
4.23.7 Alkermes Drug Delivery Devices Revenue by Geographic Area in 2021
4.23.8 Alkermes Recent Development
4.24 Skyepharma
4.24.1 Skyepharma Corporation Information
4.24.2 Skyepharma Description, Business Overview
4.24.3 Skyepharma Drug Delivery Devices Products Offered
4.24.4 Skyepharma Drug Delivery Devices Revenue and Gross Margin (2017-2022)
4.24.5 Skyepharma Drug Delivery Devices Revenue by Product in 2021
4.24.6 Skyepharma Drug Delivery Devices Revenue by Application in 2021
4.24.7 Skyepharma Drug Delivery Devices Revenue by Geographic Area in 2021
4.24.8 Skyepharma Recent Development
5 Breakdown Data by Type
5.1 Global Drug Delivery Devices Revenue by Type (2017-2022)
5.2 Global Drug Delivery Devices Revenue Forecast by Type (2023-2028)
5.3 Drug Delivery Devices Revenue Marke Share by Type (2017-2028)
6 Breakdown Data by Application
6.1 Global Drug Delivery Devices Revenue by Application (2017-2022)
6.2 Global Drug Delivery Devices Revenue Forecast by Application (2023-2028)
6.3 Drug Delivery Devices Revenue Market Share by Application (2017-2028)
7 North America
7.1 North America Drug Delivery Devices Market Size YoY Growth 2017-2028
7.2 North America Drug Delivery Devices Market Facts & Figures by Country (2017-2028)
7.3 North America Drug Delivery Devices Revenue by Type (2017-2022)
7.4 North America Drug Delivery Devices Revenue by Application (2017-2022)
8 Asia-Pacific
8.1 Asia-Pacific Drug Delivery Devices Market Size YoY Growth 2017-2028
8.2 Asia-Pacific Drug Delivery Devices Market Facts & Figures by Region (2017-2028)
8.3 Asia-Pacific Drug Delivery Devices Revenue by Type (2017-2022)
8.4 Asia-Pacific Drug Delivery Devices Revenue by Application (2017-2022)
9 Europe
9.1 Europe Drug Delivery Devices Market Size YoY Growth 2017-2028
9.2 Europe Drug Delivery Devices Market Facts & Figures by Country (2017-2028)
9.3 Europe Drug Delivery Devices Revenue by Type (2017-2022)
9.4 Europe Drug Delivery Devices Revenue by Application (2017-2022)
10 Latin America
10.1 Latin America Drug Delivery Devices Market Size YoY Growth 2017-2028
10.2 Latin America Drug Delivery Devices Market Facts & Figures by Country (2017-2028)
10.3 Latin America Drug Delivery Devices Revenue by Type (2017-2022)
10.4 Latin America Drug Delivery Devices Revenue by Application (2017-2022)
11 Middle East and Africa
11.1 Middle East and Africa Drug Delivery Devices Market Size YoY Growth 2017-2028
11.2 Middle East and Africa Drug Delivery Devices Market Facts & Figures by Country (2017-2028)
11.3 Middle East and Africa Drug Delivery Devices Revenue by Type (2017-2022)
11.4 Middle East and Africa Drug Delivery Devices Revenue by Application (2017-2022)
12 Supply Chain and Sales Channel Analysis
12.1 Drug Delivery Devices Supply Chain Analysis
12.2 Drug Delivery Devices Key Raw Materials and Upstream Suppliers
12.3 Drug Delivery Devices Clients Analysis
12.4 Drug Delivery Devices Sales Channel and Sales Model Analysis
12.4.1 Drug Delivery Devices Distribution Channel Analysis: Indirect Sales VS Direct Sales
12.4.2 Drug Delivery Devices Distribution Channel Analysis: Online Sales VS Offline Sales
12.4.3 Drug Delivery Devices Distributors
13 Market Dynamics
13.1 Drug Delivery Devices Industry Trends
13.2 Drug Delivery Devices Market Drivers
13.3 Drug Delivery Devices Market Challenges
13.4 Drug Delivery Devices Market Restraints
14 Research Findings and Conclusion
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer
List of Tables
Table 1. Global Drug Delivery Devices Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Major Companies of Injection Type
Table 3. Major Companies of Mucosal Type
Table 4. Major Companies of Implanted Type
Table 5. Major Companies of Others Type
Table 6. Global Drug Delivery Devices Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Drug Delivery Devices Market Size by Region (US$ Million): 2022 VS 2028
Table 8. Global Drug Delivery Devices Revenue by Region (2017-2022) & (US$ Million)
Table 9. Global Drug Delivery Devices Revenue Forecast by Region (2023-2028) & (US$ Million)
Table 10. Drug Delivery Devices Revenue by Company (2017-2022) & (US$ Million)
Table 11. Drug Delivery Devices Revenue Share by Company (2017-2022)
Table 12. Ranking of Global Top Drug Delivery Devices Players by Revenue (US$ Million) in 2021
Table 13. Global Drug Delivery Devices Companies Market Concentration Ratio (CR5 and HHI) & (2017-2022)
Table 14. Global Drug Delivery Devices by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Drug Delivery Devices as of 2021)
Table 15. Global Drug Delivery Devices Companies Headquarters
Table 16. Global Drug Delivery Devices Companies Product & Service
Table 17. Date of International Companies Enter into Drug Delivery Devices Market
Table 18. Global Drug Delivery Devices Mergers & Acquisitions, Expansion Plans
Table 19. Cipla Corporation Information
Table 20. Cipla Description and Business Overview
Table 21. Cipla Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 22. Cipla Drug Delivery Devices Product
Table 23. Cipla Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 24. Cipla Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 25. Cipla Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 26. Cipla Recent Development
Table 27. Baxter International Corporation Information
Table 28. Baxter International Description and Business Overview
Table 29. Baxter International Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 30. Baxter International Drug Delivery Devices Product
Table 31. Baxter International Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 32. Baxter International Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 33. Baxter International Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 34. Baxter International Recent Development
Table 35. Nipro Corporation Corporation Information
Table 36. Nipro Corporation Description and Business Overview
Table 37. Nipro Corporation Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 38. Nipro Corporation Drug Delivery Devices Product
Table 39. Nipro Corporation Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 40. Nipro Corporation Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 41. Nipro Corporation Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 42. Nipro Corporation Recent Development
Table 43. Roche Corporation Information
Table 44. Roche Description and Business Overview
Table 45. Roche Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 46. Roche Drug Delivery Devices Product
Table 47. Roche Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 48. Roche Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 49. Roche Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 50. Roche Recent Development
Table 51. Boehringer Ingelheim Corporation Information
Table 52. Boehringer Ingelheim Description and Business Overview
Table 53. Boehringer Ingelheim Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 54. Boehringer Ingelheim Drug Delivery Devices Product
Table 55. Boehringer Ingelheim Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 56. Boehringer Ingelheim Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 57. Boehringer Ingelheim Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 58. Boehringer Ingelheim Recent Development
Table 59. Allergan Corporation Information
Table 60. Allergan Description and Business Overview
Table 61. Allergan Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 62. Allergan Drug Delivery Devices Product
Table 63. Allergan Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 64. Allergan Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 65. Allergan Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 66. 3M Corporation Information
Table 67. 3M Description and Business Overview
Table 68. 3M Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 69. 3M Drug Delivery Devices Product
Table 70. 3M Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 71. 3M Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 72. 3M Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 73. BD Corporation Information
Table 74. BD Description and Business Overview
Table 75. BD Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 76. BD Drug Delivery Devices Product
Table 77. BD Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 78. BD Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 79. BD Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 80. Catalent Corporation Information
Table 81. Catalent Description and Business Overview
Table 82. Catalent Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 83. Catalent Drug Delivery Devices Product
Table 84. Catalent Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 85. Catalent Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 86. Catalent Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 87. Valeant Pharmaceuticals Corporation Information
Table 88. Valeant Pharmaceuticals Description and Business Overview
Table 89. Valeant Pharmaceuticals Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 90. Valeant Pharmaceuticals Drug Delivery Devices Product
Table 91. Valeant Pharmaceuticals Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 92. Valeant Pharmaceuticals Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 93. Valeant Pharmaceuticals Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 94. Bayer AG Corporation Information
Table 95. Bayer AG Description and Business Overview
Table 96. Bayer AG Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 97. Bayer AG Drug Delivery Devices Product
Table 98. Bayer AG Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 99. Bayer AG Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 100. Bayer AG Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 101. Chiesi Corporation Information
Table 102. Chiesi Description and Business Overview
Table 103. Chiesi Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 104. Chiesi Drug Delivery Devices Product
Table 105. Chiesi Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 106. Chiesi Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 107. Chiesi Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 108. Phillips-Medisize Corporation Information
Table 109. Phillips-Medisize Description and Business Overview
Table 110. Phillips-Medisize Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 111. Phillips-Medisize Drug Delivery Devices Product
Table 112. Phillips-Medisize Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 113. Phillips-Medisize Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 114. Phillips-Medisize Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 115. Johnson & Johnson Corporation Information
Table 116. Johnson & Johnson Description and Business Overview
Table 117. Johnson & Johnson Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 118. Johnson & Johnson Drug Delivery Devices Product
Table 119. Johnson & Johnson Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 120. Johnson & Johnson Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 121. Johnson & Johnson Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 122. Shandong Weigao Corporation Information
Table 123. Shandong Weigao Description and Business Overview
Table 124. Shandong Weigao Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 125. Shandong Weigao Drug Delivery Devices Product
Table 126. Shandong Weigao Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 127. Shandong Weigao Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 128. Shandong Weigao Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 129. Pfizer Corporation Information
Table 130. Pfizer Description and Business Overview
Table 131. Pfizer Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 132. Pfizer Drug Delivery Devices Product
Table 133. Pfizer Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 134. Pfizer Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 135. Pfizer Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 136. B.Braun Corporation Information
Table 137. B.Braun Description and Business Overview
Table 138. B.Braun Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 139. B.Braun Drug Delivery Devices Product
Table 140. B.Braun Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 141. B.Braun Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 142. B.Braun Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 143. Novartis AG Corporation Information
Table 144. Novartis AG Description and Business Overview
Table 145. Novartis AG Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 146. Novartis AG Drug Delivery Devices Product
Table 147. Novartis AG Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 148. Novartis AG Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 149. Novartis AG Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 150. Zhengkang Corporation Information
Table 151. Zhengkang Description and Business Overview
Table 152. Zhengkang Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 153. Zhengkang Drug Delivery Devices Product
Table 154. Zhengkang Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Product in 2021
Table 155. Zhengkang Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Application in 2021
Table 156. Zhengkang Drug Delivery Devices Revenue Proportion of Drug Delivery Devices by Geographic Area in 2021
Table 157. Gerresheimer Corporation Information
Table 158. Gerresheimer Description and Business Overview
Table 159. Gerresheimer Drug Delivery Devices Revenue (US$ Million) and Gross Margin (2017-2022)
Table 160. Gerresheimer Drug Delivery Devices Product
  • Global Pulmonary Drug Delivery Systems Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 143
    According to our LPI (LP Information) latest study, the global Pulmonary Drug Delivery Systems market size was valued at US$ 2979.8 million in 2023. With growing demand in downstream market, the Pulmonary Drug Delivery Systems is forecast to a readjusted size of US$ 4016.5 million by 2030 with a CAGR of 4.4% during review period. The research report highlights the growth potential of the global Pulmonary Drug Delivery Systems market. Pulmonary Drug Delivery Systems are expected to show s......
  • Global Metered Dose Inhalers Market Research Report 2024
    Published: 04-Jan-2024        Price: US 2900 Onwards        Pages: 88
    The Metered Dose Inhalers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Metered Dose Inhalers market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides pr......
  • Global Drug Delivery Devices Market Growth (Status and Outlook) 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 151
    According to our LPI (LP Information) latest study, the global Drug Delivery Devices market size was valued at US$ 40490 million in 2023. With growing demand in downstream market, the Drug Delivery Devices is forecast to a readjusted size of US$ 57290 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Drug Delivery Devices market. Drug Delivery Devices are expected to show stable growth in the future market. However......
  • Global Nebulizers Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 96
    According to our LPI (LP Information) latest study, the global Nebulizers market size was valued at US$ 844.1 million in 2023. With growing demand in downstream market, the Nebulizers is forecast to a readjusted size of US$ 1194.4 million by 2030 with a CAGR of 5.1% during review period. The research report highlights the growth potential of the global Nebulizers market. Nebulizers are expected to show stable growth in the future market. However, product differentiation, reducing costs, ......
  • Global Inhalation Therapy Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 114
    According to our LPI (LP Information) latest study, the global Inhalation Therapy Nebulizer market size was valued at US$ 1111.6 million in 2023. With growing demand in downstream market, the Inhalation Therapy Nebulizer is forecast to a readjusted size of US$ 1755.2 million by 2030 with a CAGR of 6.7% during review period. The research report highlights the growth potential of the global Inhalation Therapy Nebulizer market. Inhalation Therapy Nebulizer are expected to show stable growth......
  • Global Medical Nebulizer Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 112
    According to our LPI (LP Information) latest study, the global Medical Nebulizer market size was valued at US$ 1082.4 million in 2023. With growing demand in downstream market, the Medical Nebulizer is forecast to a readjusted size of US$ 1836.1 million by 2030 with a CAGR of 7.8% during review period. The research report highlights the growth potential of the global Medical Nebulizer market. Medical Nebulizer are expected to show stable growth in the future market. However, product diff......
  • Global Intrathecal Pumps Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 75
    According to our LPI (LP Information) latest study, the global Intrathecal Pumps market size was valued at US$ 263.7 million in 2023. With growing demand in downstream market, the Intrathecal Pumps is forecast to a readjusted size of US$ 345.7 million by 2030 with a CAGR of 3.9% during review period. The research report highlights the growth potential of the global Intrathecal Pumps market. Intrathecal Pumps are expected to show stable growth in the future market. However, product differ......
  • Global Intranasal Drug Delivery Devices Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 94
    According to our LPI (LP Information) latest study, the global Intranasal Drug Delivery Devices market size was valued at US$ 1118.1 million in 2023. With growing demand in downstream market, the Intranasal Drug Delivery Devices is forecast to a readjusted size of US$ 2382.3 million by 2030 with a CAGR of 11.4% during review period. The research report highlights the growth potential of the global Intranasal Drug Delivery Devices market. Intranasal Drug Delivery Devices are expected to s......
  • Global Drug Delivery Devices Market 2024 by Company, Regions, Type and Application, Forecast to 2030
    Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 156
    According to our (Global Info Research) latest study, the global Drug Delivery Devices market size was valued at USD 42590 million in 2023 and is forecast to a readjusted size of USD 58700 million by 2030 with a CAGR of 4.7% during review period. Drug delivery devices are used to delivery drug to the specific part of body or cure some disease. With the help of drug delivery devices, drug can efficiently reach the target and be in a controlled manner. Generally, there are several of drug ......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs